Who is sponsoring NCT04725357?

NCT04725357 is sponsored by Rothman Institute Orthopaedics.

What condition does NCT04725357 study?

NCT04725357 studies Shoulder Pain.

What drugs are being tested in NCT04725357?

Interventions: Meloxicam 15 mg, Preoperative Interscalene Nerve Block, arthroscopic labral repair.

What is the status of NCT04725357?

NCT04725357 is currently UNKNOWN.

Last reviewed 2021-01-26 · How we verify

Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?

NCT04725357 PHASE3 UNKNOWN

The opioid epidemic continues to be a major concern, with orthopedic surgeons being among the top prescribers of opioids. Studies evaluating these practices found that opioids are overprescribed, even for common procedures. Patients undergoing arthroscopic labrum repair of the shoulder were found to have an average of 20 pills left over after surgery. Many strategies have been developed to tackle overprescribing and have found success, including no opioid protocols for carpal tunnel release. The purpose of this study is to examine if meloxicam alone provides similar patient reported outcomes to opioids following arthroscopic labrum repair of the shoulder.

Details

Lead sponsor	Rothman Institute Orthopaedics
Phase	PHASE3
Status	UNKNOWN
Enrolment	96
Start date	Mon Jan 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Shoulder Pain

Interventions

Meloxicam 15 mg
Preoperative Interscalene Nerve Block
arthroscopic labral repair

Countries

United States